Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people : systematic review and economic evaluation

Duarte, Ana orcid.org/0000-0002-0528-4773, Mebrahtu, Teumzghi, Goncalves, Pedro Saramago orcid.org/0000-0001-9063-8590 et al. (6 more authors) (2017) Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people : systematic review and economic evaluation. Health technology assessment. ISSN 2046-4924

Abstract

Metadata

Authors/Creators:
Keywords: Adalimumab/economics,Adolescent,Anti-Inflammatory Agents, Non-Steroidal/therapeutic use,Anti-Inflammatory Agents/therapeutic use,Child,Cost-Benefit Analysis,Dermatologic Agents/therapeutic use,Etanercept/therapeutic use,Humans,Psoriasis/drug therapy,Treatment Outcome,Ustekinumab/therapeutic use
Dates:
  • Accepted: 3 November 2017
  • Published: 6 November 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Depositing User: Pure (York)
Date Deposited: 09 Nov 2017 14:20
Last Modified: 12 Dec 2019 00:11
Published Version: https://doi.org/10.3310/hta21640
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.3310/hta21640
Related URLs:

Download

Filename: 3011458.pdf

Description: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation

Share / Export

Statistics